FDA Digs In Heels On Orphan Drug Exclusivity
The U.S. Food and Drug Administration said Monday that a recent court defeat won't stop it from withholding exclusivity for new orphan drugs that are essentially the same as previously approved...To view the full article, register now.
Already a subscriber? Click here to view full article